A CKGSB Knowledge Series Event
When: 5:00PM – 6:30PM Thursday, November 17, 2016
Where: CKGSB New York Office
601 Lexington Ave., Floor 26
New York, NY 10022
Join us for a panel discussion on bridging the delivery gaps between the Chinese and American healthcare systems. Experts including Dr Henry Cao and Dr Lin Ning will share their knowledge of the disparities and similarities between the two countries in terms of quality of care, pharmaceutical & device market regulation and innovation.
Individual event is at a $30 fee; free for 2016 CKGSB Knowledge Series Members. Event is free to credentialed media.
SPACE IS LIMITED. RESERVE YOUR SPOT HERE.
|5:00PM – 5:15PM||Registration|
|5:15PM – 5:20PM||Welcome Remarks by Mrs Mary Wadsworth Darby, Chief Representative of Cheung Kong Graduate School of Business (CKGSB) Americas|
|5:20PM – 6:10PM||Panel Discussion led by Mrs Darby with:
|6:10PM – 6:25PM||Q&A|
|6:25PM – 6:30PM||Closing Remarks by Ms. Julie Zhu, Program Manager of CKGSB Americas|
ABOUT THE SPEAKERS
Dr Cao Huining (Henry) is a Professor of Finance, Chair of the Finance Department and the Academic Director of the Finance MBA at CKGSB. He earned a PhD in Finance in 1995 from UCLA and a PhD in Pathology in 1991 from Yale University.
Before joining CKGSB, he taught at UC Berkeley, UCSD, Ohio State University, Carnegie Mellon and UNC Chapel Hill.
Cao’s research has been published in journals including Journal of Finance, Review of Financial Studies, Journal of Financial Economics, Journal of Economic Theory, Journal of Business, Review of Finance and Marketing Science. Cao is the co-editor of International Financial Review and sits on the editorial board of Annals of Economics and Finance and China Financial Review.
Dr Lin Ning is an award-winning neurosurgeon who brings a unique combination of neurosurgical and endovascular experience in treating a wide range of vascular diseases of the brain and spine. Dr Lin has expertise in the treatment of cerebrovascular disorders including aneurysms, AVMs, carotid stenosis, cavernous malformations, Moyamoya disease, intracranial atherosclerotic disease, and intracranial hemorrhage. He also specializes in the treatment of brain and spinal tumors, pituitary tumors, and Chiari malformations. Dr Lin sees patients and performs surgery at New York-Presbyterian/Weill Cornell Medical Center and New York Hospital Queens, which is a member of the New York-Presbyterian Healthcare System and an affiliate of Weill Cornell Medical College.
Dr Lin received his Bachelor of Science degree in biomedical engineering from Duke University and was given the Leonardo da Vinci Award upon graduation. He obtained his MD degree and graduated cum laude from Harvard Medical School. Dr Lin completed his neurosurgery residency and served as chief resident at the Brigham and Women’s Hospital and Boston Children’s Hospital, and obtained fellowship training in endovascular neurosurgery and interventional neuroradiology at the Gates Vascular Institute, SUNY Buffalo.
Dr Shu Li is the Director (Asia) at New York-Presbyterian Global Services. She has a background in consulting with McKinsey & Company, specializing in hospital and healthcare system strategy, operations improvement, and organization building. Prior to joining NYP, she worked at Starcastle Senior Living (a Fosun-Fortress joint venture) in Shanghai, China, leading the operations and business development of its flagship community. Shu holds an MPH in Health Care Management and Policy from Harvard School of Public Health and a PhD in Organizational Communication from Northwestern University. Shu is responsible for seeking out strategic collaborations with providers and institutions in Asia. Shu is tasked with expanding NYP’s capabilities to provide advisory services, clinical program development, and education and training programs to international collaborators.
Mr Todd Zive was appointed Vice President, Worldwide Marketing of MicroVention, Inc. in April 2014 having served previously as Director of Marketing for Neurovascular Products since joining the Company in 2010. Mr. Zive has more than 15 years of experience in the medical device industry where he has held various engineering and product managing positions with firms such as Applied Medical, ev3 (Covidien), and Masimo Corporation. He holds a BS degree in Biomedical Engineering from Boston University and an MBA from the University of California, Irvine.
Dr Wang Duo is Director of Market Intelligence at Stryker, a Fortune 500 medical technology company. She is responsible for tracking customer needs and market dynamics, and for driving a fact-based decision making process. She has more than 10 years of experience leading strategy development, market research and data analytics in medical device, pharmaceutical and biotechnology fields. Prior to Stryker, she worked at Medtronic, Covidien and Strategic Decision Group.
Dr. Wang earned her PhD in Neuroscience at Harvard University and BSc in Physiology and Biophysics at Peking University. She was a founder of Asian Impact @ Medtronic, Colorado and served as president of Harvard Chinese Students and Scholars Association.
Disseminating deep ideas for China success
Ideas are the currency of our age. And in an age when China’s global significance is growing, CKGSB Americas’ Knowledge Series is the U.S. and Americas executive’s go-to source for a stream of provocative notions that can beneficially affect the way he or she thinks about building and expanding a China business.
Held in our state-of-the-art New York learning center in the heart of one of the world’s great financial hubs, our Knowledge Series lectures and discussions are an opportunity to learn from the world’s brightest minds as they focus on the topics and trends that are most pertinent to your specific China business goals.
Among other themes, Knowledge Series events have examined China’s financial turbulence and what it means for investors; business to business buying: how it has changed, and how we need to change with it; solar power’s future in the U.S. and China; new consumption trends in China and their implication for companies in China’s global supplier network; doing business with a changing China; and where China is and where it is headed.
Regardless of your China interest, Knowledge Series events are your gateway to acquiring critical insight on macro trends, emerging opportunities, collaboration and competition with Chinese companies, cross-cultural competencies and how to best position China within your own organization.
In an era when ideas matter, the CKGSB Americas Knowledge Series is the authoritative generator of China ideas.
QUESTIONS OR MORE INFO PLEASE CONTACT:
Cheung Kong Graduate School of Business
C | K | G | S | B